Related references
Note: Only part of the references are listed.Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study
Carina Eklund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer
Gordana Halec et al.
JOURNAL OF PATHOLOGY (2014)
The human papillomavirus family and its role in carcinogenesis
Massimo Tommasino
SEMINARS IN CANCER BIOLOGY (2014)
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
Markus Schmitt et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer
Gordana Halec et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
Markus Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
Davit Bzhalava et al.
VIROLOGY (2013)
Changes in type-specific human papillomavirus load predict progression to cervical cancer
Christophe E. Depuydt et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc Arbyn et al.
VACCINE (2012)
Worldwide burden of cervical cancer in 2008
M. Arbyn et al.
ANNALS OF ONCOLOGY (2011)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium
Marc Arbyn et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia
F. Xavier Bosch et al.
VACCINE (2008)
E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development
Mariam Mansour et al.
VIROLOGY (2007)
Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidermiologic risk classification
Thomas Hiller et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
A study of the impact of adding HPV types to cervical cancer screening and triage tests
M Schiffman et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Share Paper
